FindTrial
Sign In

Aggressive surgical approach with major vascular resection for retroperitoneal sarcomas

Aggressive surgical approach with major vascular resection for retroperitoneal sarcomas

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066276
Enrollment
Unknown
Registered
2022-11-30
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retroperitoneal sarcomas

Interventions

Vascular resection group:N/A
No vascular resection group:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 18 and over who were diagnosed with primary/recurrent retroperitoneal soft tissue sarcoma in West China Hospital of Sichuan University from January 2015 to December 2020 and underwent surgery.

Exclusion criteria

Exclusion criteria: (1) Soft tissue sarcoma originating from intestine, kidney, adrenal gland, pancreas, prostate, ovary, uterus and muscle; (2) Surgery or emergency surgery not related to tumor; (3) The pathological diagnosis is not clear; (4) Lost to follow-up during the follow-up period.

Design outcomes

Primary

MeasureTime frame
30-d mortality rate;complication rate;—

Secondary

MeasureTime frame
Length of stay;Length of ICU stay;VTE rate;Overall survival;Disease-free survival;—

Countries

China

Contacts

Public ContactQiang Guo

West China Hospital, Sichuan University

rosebud-1@163.com+8618980606400

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026